ABSTRACT
BACKGROUND: Angiogenesis is of utmost importance for tissue regeneration and repair. Human dental pulp stromal cells (hDPSCs) possess angiogenic potential, as they secrete paracrine factors that may alter the host microenvironment. However, more insight into how hDPSCs guide endothelial cells (ECs) in a paracrine fashion is yet to be obtained. Therefore, the current study aimed to investigate the effect(s) of conditioned medium derived from hDPSCs (hDPSC-CM) on EC behavior in vitro. METHODS: hDPSCs were harvested from third molars scheduled for surgical removal under informed consent. The angiogenic profile of hDPSC-CM was identified using human angiogenesis antibody array and enzyme-linked immunosorbent assay (ELISA). Using real-time reverse transcription-polymerase chain reaction (RT-PCR) and ELISA, the mRNA and protein expression level of specific angiogenic biomarkers was determined in human umbilical vein endothelial cells (HUVECs) exposed to hDPSC-CM. The effect of hDPSC-CM on HUVEC attachment, proliferation and migration was evaluated by crystal violet staining, MTT, transwell migration along with real-time cell monitoring assays (xCELLigence; ACEA Biosciences, Inc.). A Matrigel assay was included to examine the influence of hDPSC-CM on HUVEC network formation. Endothelial growth medium (EGM-2) and EGM-2 supplemented with hDPSC-CM served as experimental groups, whereas endothelial basal medium (EBM-2) was set as negative control. RESULTS: A wide range of proangiogenic and antiangiogenic factors, including vascular endothelial growth factor, tissue inhibitor of metalloproteinase protein 1, plasminogen activator inhibitor (serpin E1), urokinase plasminogen activator and stromal cell-derived factor 1, was abundantly detected in hDPSC-CM by protein profiling array and ELISA. hDPSC-CM significantly accelerated the adhesion phases, from sedimentation to attachment and spreading, the proliferation rate and migration of HUVECs as shown in both endpoint assays and real-time cell analysis recordings. Furthermore, Matrigel assay demonstrated that hDPSC-CM stimulated tubulogenesis, affecting angiogenic parameters such as the number of nodes, meshes and total tube length. CONCLUSIONS: The sustained proangiogenic and promaturation effects of hDPSC-CM shown in this in vitro study strongly suggest that the trophic factors released by hDPSCs are able to trigger pronounced angiogenic responses, even beyond EGM-2 considered as an optimal culture condition for ECs.
Subject(s)
Culture Media, Conditioned/pharmacology , Human Umbilical Vein Endothelial Cells/cytology , Mesenchymal Stem Cells/metabolism , Cells, Cultured , Chemokine CXCL12/analysis , Chemokine CXCL12/metabolism , Culture Media, Conditioned/chemistry , Dental Pulp/cytology , Human Umbilical Vein Endothelial Cells/drug effects , Humans , Plasminogen Activator Inhibitor 1/analysis , Plasminogen Activator Inhibitor 1/metabolism , Plasminogen Activators/analysis , Plasminogen Activators/metabolismABSTRACT
BACKGROUND AND OBJECTIVE: The aim of this study was to evaluate the effect of nonsurgical periodontal therapy on clinical parameters and gingival crevicular fluid levels of tissue/blood vessel-type plasminogen activator (t-PA) and plasminogen activator inhibitor-2 (PAI-2) in patients with periodontitis, with or without rheumatoid arthritis (RA). MATERIAL AND METHODS: Fifteen patients with RA and chronic periodontitis (RA-P), 15 systemically healthy patients with chronic periodontitis (H-P) and 15 periodontally and systemically healthy volunteers (C) were included in the study. Plaque index, gingival index, probing pocket depth, clinical attachment level, bleeding on probing, gingival crevicular fluid t-PA and PAI-2 levels, erythrocyte sedimentation rate, serum C-reactive protein and disease activity score were evaluated at baseline and 3 mo after mechanical nonsurgical periodontal therapy. RESULTS: All periodontal clinical parameters were significantly higher in the RA-P and H-P groups compared with the C group (p < 0.001) and decreased significantly after treatment (p < 0.001). Pretreatment t-PA levels were highest in the RA-P group and significantly decreased post-treatment (p = 0.047). Pre- and post-treatment PAI-2 levels were significantly lower in controls compared with both periodontitis groups (p < 0.05). Gingival crevicular fluid volume and the levels of t-PA and PAI-2 were significantly correlated. CONCLUSION: In patients with periodontitis and RA, nonsurgical periodontal therapy reduced the pretreatment gingival crevicular fluid t-PA levels, which were significantly correlated with gingival crevicular fluid PAI-2 levels. The significantly higher t-PA and PAI-2 gingival crevicular fluid levels in periodontal patients, regardless of systemic status, suggest that the plasminogen activating system plays a role in the disease process of periodontitis.
Subject(s)
Arthritis, Rheumatoid/metabolism , Chronic Periodontitis/complications , Gingival Crevicular Fluid/chemistry , Plasminogen Activator Inhibitor 2/analysis , Plasminogen Activators/analysis , Adult , Arthritis, Rheumatoid/complications , Blood Sedimentation , C-Reactive Protein/analysis , Case-Control Studies , Chronic Periodontitis/metabolism , Chronic Periodontitis/therapy , Dental Plaque Index , Dental Scaling , Female , Humans , Male , Middle Aged , Periodontal Attachment Loss/complications , Periodontal Attachment Loss/metabolism , Periodontal Attachment Loss/therapy , Periodontal Index , Root PlaningABSTRACT
Plasminogen activators/Plasmin system plays pivotal role in regulating reproductive functions of mammals. Here, we examined the effects of modification of in vitro fertilization medium (IVF medium) with the addition of tissue-type plasminogen activator (t-PA), on bovine embryo development and quality, assessed by quantification of expression of various genes related to metabolism, oxidation, implantation and apoptosis. In addition, plasminogen activator activity (PAA) and plasminogen activator inhibition (PAI) were measured in the spent media. After conventional IVM, 2016 cumulus-oocyte complexes (COCs) were divided into four groups with modified composition of the IVF medium containing t-PA and/or its inhibitor epsilon-aminocaproic acid (control, t-PA, t-PA+ε-ACA, ε-ACA). Presumptive zygotes were cultured for 8 days in synthetic oviductal fluid (SOF) medium; gene expression studies were carried out on morulae and blastocysts. t-PA alone significantly suppressed cleavage and blastocyst formation rates, but this effect was neutralized by the addition of ε-ACA. PAA in the treated group was significantly reduced by ε-ACA, but without total elimination. Significant differences were detected in the expression of genes related to apoptosis and/or cell cycle arrest (BAX, BCL2L1, KAT2B) between embryos produced in t-PA-modified media and controls, giving an overall notion that the inferior developmental competence of treated embryos may be attributed to apoptotic phenomena induced by t-PA. In conclusion, it appears that excessive t-PA content in the IVF media, suppresses blastocyst formation rate, possibly due to induction of apoptotic phenomena.
Subject(s)
Cattle/embryology , Embryonic Development/drug effects , Fertilization in Vitro/veterinary , Gene Expression/drug effects , Tissue Plasminogen Activator/pharmacology , Animals , Apoptosis/genetics , Blastocyst/metabolism , Cell Cycle Checkpoints/genetics , Culture Media , Embryo Culture Techniques , Embryo Implantation/genetics , Female , Fertilization in Vitro/methods , In Vitro Oocyte Maturation Techniques , Male , Metabolism/genetics , Morula/metabolism , Oxidation-Reduction , Plasminogen Activators/analysis , Plasminogen Inactivators/analysis , Tissue Plasminogen Activator/adverse effects , Tissue Plasminogen Activator/analysisABSTRACT
Recombinant plasminogen activator (r-PA, reteplase) is an engineered variant of alteplase. When expressed in E. coli, it appears as inclusion bodies that require refolding to recover its biological activity. An important step following refolding is to determine the activity of refolded protein. Current methods for enzymatic activity of thrombolytic drugs are costly and complex. Here a straightforward and low-cost clot lysis assay was developed. It quantitatively measures the activity of the commercial reteplase and is also capable of screening refolding conditions. As evidence for adequate accuracy and sensitivity of the current assay, r-PA activity measurements are shown to be comparable to those obtained from chromogenic substrate assay.
Subject(s)
Fibrinolysis , Fibrinolytic Agents/analysis , Plasminogen Activators/analysis , Escherichia coli/genetics , Escherichia coli/metabolism , Plasminogen Activators/genetics , Recombinant Proteins/analysis , Recombinant Proteins/genetics , Sensitivity and SpecificityABSTRACT
Despite membrane-based separations offering superior alternative to packed bed chromatographic processes, there has been a substantial lacuna in their actual application to separation processes. One of the major reasons behind this is the lack of availability of appropriately modified or end-group modifiable membranes. In this paper, an affinity membrane was developed using a commercially available serine protease inhibitor, para-aminobenzamidine (pABA). The membrane modification was optimized for protein binding capacity by varying: (i) the length of the spacer arm (SA; 5-atoms, 7-atoms, and 14-atoms) linking the ligand to membrane surface; (ii) the affinity ligand (pABA) density on membrane surface (5-25nmol/cm(2)). Resulting membranes were tested for their ability to bind plasminogen activators (PAs) from mono- and multi-component systems in batch mode. The membrane containing pABA linked through 7-atoms SA but similar ligand density as in the case of 5- or 14-atoms long SA was found to bind up to 1.6-times higher amounts of PA per nmoles of immobilized ligand from conditioned HeLa cell culture media. However, membranes with similar ligand densities but different lengths of SA, showed comparable binding capacities in mono-component system. In addition, the length of SA did not affect the selectivity of the ligand for PA. A clear inverse linear correlation was observed between ligand density and binding capacity until the point of PA binding optima was reached (11±1.0nmol/cm(2)) in mono- and multi-component systems for 7- as well as 14-atoms SA. Up to 200-fold purification was achieved in a single step separation of PA from HeLa conditioned media using these affinity membranes. The issues of ligand leaching and reuse of the membranes were also investigated. An extensive regeneration procedure allowed the preservation of approximately 95% of the PA binding capacity of the membranes even after five cycles of use.
Subject(s)
Benzamidines/chemistry , Cellulose/chemistry , Chromatography, Affinity/instrumentation , Chromatography, Affinity/methods , Membranes, Artificial , Plasminogen Activators/isolation & purification , Equipment Reuse , Fibrin/chemistry , Fibrin/metabolism , HeLa Cells , Humans , Microscopy, Confocal , Models, Molecular , Plasminogen Activators/analysis , Plasminogen Activators/chemistryABSTRACT
Yersinia pestis, the plague bacillus, has a rodent-flea-rodent life cycle but can also persist in the environment for various periods of time. There is now a convenient and effective test (F1-dipstick) for the rapid identification of Y. pestis from human patient or rodent samples, but this test cannot be applied to environmental or flea materials because the F1 capsule is mostly produced at 37°C. The plasminogen activator (PLA), a key virulence factor encoded by a Y. pestis-specific plasmid, is synthesized both at 20°C and 37°C, making it a good candidate antigen for environmental detection of Y. pestis by immunological methods. A recombinant PLA protein from Y. pestis synthesized by an Escherichia coli strain was used to produce monoclonal antibodies (mAbs). PLA-specific mAbs devoid of cross-reactions with other homologous proteins were further cloned. A pair of mAbs was selected based on its specificity, sensitivity, comprehensiveness, and ability to react with Y. pestis strains grown at different temperatures. These antibodies were used to develop a highly sensitive one-step PLA-enzyme immunoassay (PLA-EIA) and an immunostrip (PLA-dipstick), usable as a rapid test under field conditions. These two PLA-immunometric tests could be valuable, in addition to the F1-disptick, to confirm human plague diagnosis in non-endemic areas (WHO standard case definition). They have the supplementary advantage of allowing a rapid and easy detection of Y. pestis in environmental and flea samples, and would therefore be of great value for surveillance and epidemiological investigations of plague foci. Finally, they will be able to detect natural or genetically engineered F1-negative Y. pestis strains in human patients and environmental samples.
Subject(s)
Immunoassay/methods , Plague/diagnosis , Yersinia pestis/isolation & purification , Amino Acid Sequence , Animals , Antibodies, Monoclonal/immunology , Antibody Specificity , Antigens, Bacterial/analysis , Antigens, Bacterial/biosynthesis , Antigens, Bacterial/chemistry , Antigens, Bacterial/immunology , DNA, Recombinant/genetics , Environment , Epitopes/immunology , Escherichia coli/genetics , Female , Humans , Immunoassay/instrumentation , Mice , Molecular Sequence Data , Plague/microbiology , Plasminogen Activators/analysis , Plasminogen Activators/biosynthesis , Plasminogen Activators/chemistry , Plasminogen Activators/immunology , Reagent Strips , Species Specificity , Time Factors , Yersinia pestis/immunology , Yersinia pestis/physiologySubject(s)
Disease Reservoirs , Plague/transmission , Rodent Diseases/transmission , Rodentia/microbiology , Animals , Bacterial Proteins/analysis , Bacterial Proteins/chemistry , DNA, Bacterial/analysis , Humans , Mongolia , Plague/epidemiology , Plague/microbiology , Plague/veterinary , Plasminogen Activators/analysis , Plasminogen Activators/chemistry , Polymerase Chain Reaction , Prevalence , Retrospective Studies , Rodent Diseases/epidemiology , Rodent Diseases/microbiology , Sequence Analysis, DNA , Yersinia pestis/physiologyABSTRACT
AIM: To determine sialic acids and O-acetyl groups content in Yersinia pestis and Vibrio cholerae antigens in order to establish their association with biological activity. MATERIALS AND METHODS: The following antigens of Y. pestis EV NIIEG strain--capsular antigen (F1), major somatic antigen (MSA), lipopolysaccharide (LPS), Pla-protease, allergen pestin PP--as well as O-antigens (O-AG) of V. cholerae serogroups O1 and O139 were used in the study. Sialic acids were identified by the thiobarbituric method, and O-acetyl groups--according to Alicino. Specific polysaccharides in the MSA and O-antigens were detected by the immunodiffusion assay. RESULTS: Sialic acids were found in LPS, Pla-protease, allergen pestin PP, and all cholera O-AG; their absence was demonstrated in MSA and F1. O-acetyl groups were identified in cholera O-AG of both studied serogroups as well as in LPS, Pla-protease, MSA and pestin PP of Y. pestis. Tendency to correlation between O-acetyl groups content in MSA and serological activity titer was observed. CONCLUSION: Sialic acids and O-acetyl groups identified in carbohydrate-containing antigens of Y. pestis and V. cholerae could be characterized as reaction-active markers of pathogenetic mechanisms of cholera and plague infections as well as immunochemical activity of microbial polysaccharides.
Subject(s)
Sialic Acids/analysis , Vibrio cholerae , Yersinia pestis , Allergens/analysis , Allergens/isolation & purification , Animals , Bacterial Proteins/analysis , Bacterial Proteins/isolation & purification , Biomarkers/analysis , Cell Culture Techniques , Cholera/immunology , Cholera/pathology , Humans , Immunodiffusion , O Antigens/analysis , O Antigens/isolation & purification , Plague/immunology , Plague/pathology , Plasminogen Activators/analysis , Plasminogen Activators/isolation & purification , Rodentia , Serologic Tests , Sialic Acids/immunology , Structure-Activity Relationship , Vibrio cholerae/chemistry , Vibrio cholerae/immunology , Yersinia pestis/chemistry , Yersinia pestis/immunologyABSTRACT
Haemostatic parameters: platelet aggregation, hematocrit, fibrinogen, antithrombin III, fibrinolytic activity and euglobulin lysis time, plasminogen, plasminogen activator and anti-activator activity, thrombin- antithrombin and plasmin-antiplasmin complexes and serum von Willebrand factor were studied at the most acute stage of cardioembolic stroke (1-7 days after development of neurological symptoms). State of the vascular wall was assessed using the "cuff"-test. The activation of hemostasis in patients with cardioembolic stroke was characterized by the hypercoagulation and decrease of fibrinolysis and athrombogenic potential of vessel wall properties (antiaggregation, fibrinolytic and anticoagulative). In conclusion, haemostatic disbalance and decreasing of athrombotic potential of the vessel wall may be the indicator of embolism in patients with cardioembolic stroke.
Subject(s)
Arteriosclerosis/complications , Brain Ischemia/blood , Embolism/complications , Heart Diseases/complications , Hemostasis , Stroke/blood , Adult , Aged , Antifibrinolytic Agents/analysis , Antithrombin III/analysis , Brain Ischemia/etiology , Female , Fibrinogen/analysis , Fibrinolysin/analysis , Fibrinolysis , Humans , Male , Middle Aged , Plasminogen/analysis , Plasminogen Activators/analysis , Platelet Aggregation , Serum Globulins/analysis , Stroke/etiology , Thrombin/analysis , von Willebrand Factor/analysis , von Willebrand Factor/immunologyABSTRACT
OBJECTIVE: Proteases are considered critical in peri-cystic tissue degradation required in jaw cyst expansion. We studied the expression of the plasminogen activation system (plasminogen activators; their inhibitor type-1, PAI-1; the receptor for the urokinase-type plasminogen activator, uPAR) in follicular and inflammatory cysts of the jaw, to identify a possible role of this system in jaw cyst enlargement. MATERIALS AND METHODS: Jaw cysts were collected by therapeutic enucleation. ELISA and casein zymography were used to measure and characterize plasminogen activators in cyst fluid. By immunohistochemistry we examined the presence of uPAR in cyst walls and inflammatory cells, and by Western blotting the molecular forms of uPAR within the cyst fluid. RESULTS: Inflammatory cysts fluid contained higher amounts of plasminogen activators of the urinary-type (uPA), and lower amounts of PAI-1, when compared to follicular cysts fluid. Epithelial layers of both types of cysts and inflammatory cells expressed uPAR. Native 3-domain uPAR was scarcely detectable within cysts, where its cleavage was accounted for by uPA. CONCLUSION: These data suggest a plasminogen activation-dependent mechanism of cyst enlargement, where only the outward uPAR expressed on epithelial cells and on inflammatory cells direct the peri-cystic protease cascade, in a way similar to tumor enlargement within tissues.
Subject(s)
Jaw Cysts/pathology , Odontogenic Cysts/pathology , Receptors, Urokinase Plasminogen Activator/analysis , Urokinase-Type Plasminogen Activator/analysis , Adult , Aged , Aged, 80 and over , Blotting, Western , Cyst Fluid/chemistry , Epithelial Cells/enzymology , Epithelial Cells/pathology , Female , Humans , Immunohistochemistry , Inflammation , Jaw Cysts/enzymology , Leukocyte Common Antigens/analysis , Male , Middle Aged , Odontogenic Cysts/enzymology , Plasminogen Activator Inhibitor 1/analysis , Plasminogen Activators/analysisABSTRACT
OBJECTIVE: The aim of this study was to investigate the effect of intra-articular sodium hyaluronate (SH) injections on the main components of plasminogen activator (PA) system in the synovial fluid of temporomandibular joint (TMJ) osteoarthritis (OA). STUDY DESIGN: Forty patients diagnosed with TMJ OA and 20 healthy control subjects were included in this study. Synovial fluid was collected in the OA group and the healthy group at baseline. The OA patients were randomly divided into 2 groups (20 patients for each group): One group received 5 injections of SH, and the other received 5 injections of physiologic saline solution in the upper joint space at weekly intervals. Synovial fluid was collected before and after treatment. Urokinase-type PA (uPA), soluble uPA receptor (suPAR) and PA inhibitor 1 (PAI-1) levels in synovial fluid were quantified by enzyme-linked immunosorbent assay. RESULTS: The OA patients had significantly higher uPA activity and levels of uPA (median 80.01 ng/L), suPAR (median 7.54 ng/L), and PAI-1 (median 54.9 ng/mL) than the healthy control subjects (median 20.47 ng/L uPA, 2.34 ng/L suPAR, and 19.9 ng/mL PAI-1; (P < .05). The uPA activity and levels of uPA, suPAR, and PAI-1 were significantly decreased after SH injections in TMJs of OA patients (P < .05), and there was no difference after saline injection. Visual analog pain score reduction correlated with changes in uPA and uPAR levels as well as uPA activity. CONCLUSION: The effects of SH on PA system provide new insight into a possible underlying mechanism by which SH alleviates pain of patients with TMJ OA.
Subject(s)
Hyaluronic Acid/therapeutic use , Osteoarthritis/drug therapy , Plasminogen Activators/drug effects , Synovial Fluid/drug effects , Temporomandibular Joint Disorders/drug therapy , Viscosupplements/therapeutic use , Adult , Electrophoresis, Polyacrylamide Gel , Female , Humans , Hyaluronic Acid/administration & dosage , Injections, Intra-Articular , Male , Middle Aged , Pain Measurement , Plasminogen Activator Inhibitor 1/analysis , Plasminogen Activators/analysis , Receptors, Urokinase Plasminogen Activator/analysis , Single-Blind Method , Synovial Fluid/chemistry , Urokinase-Type Plasminogen Activator/analysis , Viscosupplements/administration & dosageABSTRACT
This article discusses the optimization of a newly developed method for measuring the activity of plasminogen activators using a thickness-shear-mode acoustic sensor. A variable-size simplex algorithm was used for optimization. Preliminary tests were performed to design the first simplex. A desirability function was defined to translate each performance value to a membership value of 0 to 1. If there was more than one performance variable, their membership values were translated to an aggregated membership value using another function that considers their individual influence on sensor performance. Two rounds of optimization were carried out for streptokinase followed by a single optimization for tissue-type plasminogen activator. In the last optimization, ratios of control variables were used in order to reduce the number of parameters and to formulate easily adjustable assay conditions. The results showed the usefulness of the simplex method for optimizing this type of assay, and the importance of preliminary tests and prior knowledge in providing rapid convergence using fewer experiments. The optimized plasminogen activator assay can be considered a reference method for measurement of all members of this drug class.
Subject(s)
Acoustics , Algorithms , Chemistry Techniques, Analytical/methods , Plasminogen Activators/analysis , Plasminogen Activators/metabolism , Reproducibility of Results , Sensitivity and Specificity , Temperature , Time FactorsABSTRACT
A reliable method for the measurement of different plasminogen activators is of great interest for both manufacturing and clinical medicine. A one-step assay based on a thickness shear mode acoustic sensor has been developed for this purpose. Two separate mixtures of substrates (fibrinogen and plasminogen) and enzymes (thrombin and the plasminogen activator) were mixed, and placed on the acoustic sensor surface. During the assay, the resonant frequency of a quartz crystal oscillating in the thickness shear mode was measured and used to find a characteristic clot dissolution time, from the sample addition to the time at the maximum dissolution rate. Calibrations of the acoustic assay were done for tissue-type plasminogen activator (t-PA) as well as for the other plasminogen activators: urokinase (u-PA); streptokinase (SK) and staphylokinase (SAK). All gave relative standard deviations of about 12%. Since the same method was used for all of the activators, their activities were compared, resolving the differences between their unit definitions. Linear relationships were found between urokinase and streptokinase which activate plasminogen directly and between t-PA and staphylokinase which require fibrin as a cofactor. The relationship between the groups was found to curve, indicating the difference between the two mechanisms. The acoustic method, therefore, may be used as a rapid and cost-effective reference method for the standardization and comparison of different plasminogen activators.
Subject(s)
Acoustics , Biosensing Techniques/methods , Plasminogen Activators/analysis , Caseins/metabolism , Fibrin/metabolism , Fibrinogen/metabolism , Fibrinolysin/metabolism , Fibrinolysis/physiology , Fibrinolytic Agents/metabolism , Metalloendopeptidases/analysis , Metalloendopeptidases/metabolism , Plasminogen/metabolism , Plasminogen Activators/metabolism , Streptokinase/analysis , Streptokinase/metabolism , Thrombosis/metabolism , Thrombosis/pathology , Urokinase-Type Plasminogen Activator/analysis , Urokinase-Type Plasminogen Activator/metabolismABSTRACT
Prostate cancer, the most prevalent non-cutaneous cancer in men, is associated with increased age. This suggests that dietary chemopreventive measures could be effective in delaying the onset or decreasing the severity of the disease. We utilized the Lobund-Wistar rat nitrosomethylurea induced, testosterone promoted (NMU-T) model of male sex accessory gland cancer to test the potential chemopreventive effects of myo-inositol and limonene on tumor incidence and associated protease activities. Tumors were found to arise in the seminal vesicles and dorsal and anterior prostate lobes. There were also some tumors that appeared to arise in both the seminal vesicles and anterior prostate, and in some cases the tissue of origin was not clear. The distribution of tumors as to site of origin in limonene or myo-inositol treated animals did not vary from that of the starch fed control animals, and the number of animals presenting with metastases did not vary significantly between treatment groups. There was a statistically significant delay in onset of tumors in myo-inositol, but not limonene fed rats, at 10 months post-induction of carcinogenesis; however, at 12 and 15 months this was not significant. The ventral prostate and seminal vesicles expressed pro-MMP-2 and plasminogen activator (PA) activities. Based on sensitivity to amiloride, the PA activities were predominately urokinase (uPA) in the ventral prostate and a mixture of tissue-type activator (tPA) and uPA in the seminal vesicles of non-treated rats. Sex accessory gland tumors, and metastases, expressed increased levels PA and pro- and active forms of MMP-2 and -9. The PA activities of the tumors were a mixture of uPA and tPA. There was no difference in the levels of these protease activities based on the tissue of tumor origin, nor in tumor vs metastasis. These studies indicate that MMP and PA activities play a role in sex accessory gland tumor biology and that dietary supplementation with myo-inositol can delay but not ultimately prevent the development of such tumors.
Subject(s)
Cyclohexenes/therapeutic use , Dietary Supplements , Genitalia, Male/pathology , Inositol/therapeutic use , Matrix Metalloproteinases/biosynthesis , Neoplasms/prevention & control , Plasminogen Activators/metabolism , Terpenes/therapeutic use , Alkylating Agents/toxicity , Animals , Anticarcinogenic Agents/therapeutic use , Disease Models, Animal , Genitalia, Male/enzymology , Genitalia, Male/metabolism , Incidence , Limonene , Male , Matrix Metalloproteinases/analysis , Methylnitrosourea/toxicity , Neoplasms/chemically induced , Plasminogen Activators/analysis , Random Allocation , Rats , Rats, Wistar , Time FactorsABSTRACT
A new procedure is presented for the measurement of plasminogen activators using a thickness shear mode sensor and a modified version of the fibrin plate assay at the micro-scale. Separate, well-mixed solutions of the substrates fibrinogen and plasminogen, and enzymes thrombin and the plasminogen activator sample were mixed together and placed on the sensor surface. The temperature and evaporation were controlled during the assay. The clot dissolution time correlated well with the quantity of the plasminogen activator in the sample. The average relative standard deviation was 12.5%.
Subject(s)
Acoustics , Plasminogen Activators/analysis , Blood Coagulation , Electrochemistry/methods , Fibrinogen , Humans , Plasminogen , ThrombinABSTRACT
Differentially fluorescently labeled bovine plasminogen (PG-594) and human tissue- and urokinase-type plasminogen activators (tPA-647 and uPA-546) were added to bovine skim milk to track the effect of heat on the location and concentration of these plasmin system components following acid precipitation or ultracentrifugation. In unheated milk, the majority (71.7% to 89.0%) of the added PG and PAs associated with casein micelles or acid curd, and PG-594 in the serum fraction was partially due to associations with nonsedimentable caseins. Heat treatment (85 degrees C for 16 s) significantly (P < 0.05) affected distribution of PG-594, tPA-647, and uPA-546, resulting in reduced concentrations of PG and PAs in the serum fractions and reciprocal increases in their levels in the nonsedimentable casein fractions. Overall, almost all of the added PG and PAs (95.9% to 97.5%) became associated with caseins following heat treatment. This is the 1st study to successfully use fluorescent labeling to quantify effects of heat on the location of plasmin components in skim milk.
Subject(s)
Fibrinolysin/analysis , Hot Temperature , Milk/chemistry , Plasminogen Activators/analysis , Plasminogen/analysis , Animals , Caseins/chemistry , Cattle , Chemical Precipitation , Female , Fibrinolysin/chemistry , Fibrinolysin/metabolism , Fluorescent Dyes , Micelles , Milk/enzymology , Plasminogen/chemistry , Plasminogen/metabolism , Plasminogen Activators/chemistry , Plasminogen Activators/metabolism , Tissue Plasminogen Activator/analysis , Tissue Plasminogen Activator/chemistry , Tissue Plasminogen Activator/metabolism , Ultracentrifugation , Urokinase-Type Plasminogen Activator/analysis , Urokinase-Type Plasminogen Activator/chemistry , Urokinase-Type Plasminogen Activator/metabolismABSTRACT
The aim of the present study was to investigate the effect of melatonin on plasminogen activator activity (PAA), plasminogen activator inhibition (PAI) and plasmin inhibition (PI) in ram spermatozoa and seminal plasma, in correlation with changes in blood testosterone. Melatonin implants (18 mg) were placed subcutaneously in sixteen Chios rams in autumn and spring. Semen samples for spectrophotometrical assays were collected 36 h before the implantation of melatonin and thereafter once a week, for 17 weeks. Blood samples for testosterone assay (RIA) were collected 8h before implantation (one sample/30 min x 7.5 h) and thereafter every 15 days for 105 days after implantation. For each ram, six parameters of testosterone were estimated: mean value, basal level, number of peaks, peak amplitude, peak duration and mean testosterone concentration during peaks. Melatonin implantation during autumn induced an increase in PAA and t-PAI in spermatozoa; melatonin implantation in spring induced an additional increase in u-PAI and PI; no change in PAA, PAI or PI was found in seminal plasma, during autumn or spring. The melatonin-induced increase of PAA, PAI and PI in spermatozoa was in positive correlation with the increase of testosterone mean value, basal level and number of peaks; the increase of testosterone parameters was greater in autumn compared to spring. Changes of PAA, PAI and PI of spermatozoa, under the influence of melatonin, might indicate changes in the fertilizing ability of spermatozoa, since plasminogen activators and their inhibitors are present on the plasma and the outer acrosomal membrane of spermatozoa and are released during the acrosome reaction.
Subject(s)
Melatonin/administration & dosage , Plasminogen Activators/metabolism , Sheep/metabolism , Spermatozoa/metabolism , Animals , Antifibrinolytic Agents/analysis , Drug Implants , Greece , Male , Plasminogen Activators/analysis , Plasminogen Inactivators/analysis , Seasons , Semen/chemistry , Semen/enzymology , Spermatozoa/chemistry , Spermatozoa/enzymology , Testosterone/blood , Urokinase-Type Plasminogen Activator/antagonists & inhibitorsABSTRACT
The corpus luteum (CL) offers the opportunity to study high proliferative processes during its development and degradation processes during its regression. We examined the mRNA expression of matrix metalloproteases (MMP)-1, MMP-2, MMP-9, MMP-14, MMP-19, tissue inhibitor of MMP (TIMP)-1, TIMP-2, tissue plasminogen activator (tPA), urokinase plasminogen activator (uPA), uPA-receptor (uPAR), PA-inhibitors (PAI)-1, PAI-2 in follicles 20 h after GnRH application, CLs during days 1-2, 3-4, 5-7 and 8-12 of the oestrous cycle as well as after induced luteolysis. Cows in the mid-luteal phase were injected with Cloprostenol and the CLs were collected at 0.5, 2, 4, 12, 24, 48 and 64 h after PGF2alpha injection. Real-time RT-PCR determined mRNA expressions. Expression from 20 h after GnRH to day 12: MMP-1, MMP-2, MMP-14 and tPA showed a clear expression, but no regulation. TIMP-1 and uPAR mRNA increased when compared with the follicular phase. TIMP-2, MMP-9, MMP-19 and uPA increased from the follicular phase to days 8-12. PAI-1 and PAI-2 expression increased from days 1-7 and decreased to days 8-12. Induced luteolysis: MMP-1, MMP-2, MMP-9, MMP-14, MMP-19 and TIMP-1 all increased at different time points and intensities, whereas TIMP-2 was constantly decreased from 24 to 64 h. The plasminogen activator system and their inhibitors were up-regulated from 2 to 64 h, tPA was already increased after 0.5 h. Immunohistochemistry for MMP-1, MMP-2, MMP-14: an increased staining for MMP-1 and MMP-14 was seen in large luteal cells beginning 24 h after PGF2alpha application. MMP-2 showed a strong increase in staining in endothelial cells at 48 h.
Subject(s)
Corpus Luteum/enzymology , Extracellular Matrix/enzymology , Luteolysis/physiology , Peptide Hydrolases/analysis , Animals , Cattle , Estrous Cycle/physiology , Female , Immunohistochemistry , Matrix Metalloproteinase 1/analysis , Matrix Metalloproteinase 14/analysis , Matrix Metalloproteinase 2/analysis , Matrix Metalloproteinase 9/analysis , Plasminogen Activator Inhibitor 1/analysis , Plasminogen Activator Inhibitor 1/genetics , Plasminogen Activator Inhibitor 2/analysis , Plasminogen Activator Inhibitor 2/genetics , Plasminogen Activators/analysis , Plasminogen Activators/genetics , Plasminogen Inactivators/analysis , Plasminogen Inactivators/genetics , Pregnancy , RNA, Messenger/analysis , Reverse Transcriptase Polymerase Chain Reaction , Tissue Culture Techniques , Tissue Inhibitor of Metalloproteinase-2/analysis , Tissue Inhibitor of Metalloproteinase-2/genetics , Tissue Plasminogen Activator/analysis , Tissue Plasminogen Activator/geneticsABSTRACT
The purpose of this study was to evaluate the effect of breed, stage of lactation, and health status of the udder on the plasmin-plasminogen system in ovine milk. A total of 38 ewes were used from 3 breeds [Boutsiko (n = 12), Chios (n = 12), and a synthetic breed (50% Boutsiko, 25% Arta, and 25% Chios, n = 14)] with major differences in their genetic potential with respect to milk yield. Milk samples were collected every 2 wk throughout the lactation period and were analyzed for fat, protein, lactose, and somatic cell count (SCC). In addition, milk plasmin (PL), plasminogen (PG), and plasminogen activator (PA) activities were determined. The Chios breed had the greatest average daily milk yield, the synthetic breed had an intermediate milk yield, and ewes of the Boutsiko breed had the lowest milk yield. Milk samples obtained from the Boutsiko breed had similar PL and PA activities, compared with those obtained from the other 2 breeds. The ratio of PG:PL was less in milk samples from the Boutsiko breed compared with the other 2 breeds, indicative of an increased rate of conversion of PG to PL for this breed. There was no correlation between PL activity and daily milk yield in ewes from all 3 breeds. Activities of PL, PG, and PA were greater in ovine milk with elevated SCC (>300,000/mL) compared with activities in milk with low SCC (<300,000/mL). The ratio of PG:PL was less in the high-SCC group compared with the low-SCC group, which indicates an increased rate of conversion of PG to PL for the high-SCC group. There was a decrease in PG and PA activities as well as in the PG:PL ratio in late lactation milk (mo 5 to 6) when compared with early or mid lactation milk (mo 1 to 4). Thus, the PL-PG system is affected by breed, stage of lactation, and the health status of the udder. No relationship was found between PL activity and daily milk yield in the 3 Greek dairy sheep breeds. Plasmin is not a marker for gradual involution in the Greek sheep breeds studied.
Subject(s)
Breeding , Fibrinolysin/physiology , Lactation/physiology , Milk/chemistry , Plasminogen/physiology , Sheep/physiology , Animals , Female , Fibrinolysin/analysis , Greece , Lactation/genetics , Least-Squares Analysis , Mammary Glands, Animal/physiology , Milk/cytology , Plasminogen/analysis , Plasminogen Activators/analysis , Plasminogen Activators/physiologyABSTRACT
BACKGROUND: The plasminogen activator system consists of two plasminogen activators, urokinase (uPA) and tissue (tPA); PA inhibitors (PAI-1, and -2), and a cell surface receptor for uPA (uPAR). The plasminogen activator system is involved at many stages of the metastatic cascade, including matrix remodelling, cell proliferation, and migration. AIMS: To compare tissue concentrations of the components of the plasminogen activator system in paired tumour tissue and normal tissue in patients with oral squamous cell carcinoma, and to correlate these with the histopathological grading of the tumour. METHODS: Thirty-eight paired tissue samples were analysed by enzyme-linked immunosorbent assays (ELISA; ng/mg protein) for uPA, tPA, uPAR, PAI-1, and PAI-2. RESULTS: Concentrations of uPA, uPAR, PAI-1, and PAI-2 were significantly higher in tumour than in normal oral tissue (median in uPAR tumour 1.6 (range; 0.1-7.5) ng/mg protein; normal=0.2 (0-2.3), p<0.05). There were strong correlations between the concentrations of certain components of the plasminogen activator system in particular between uPA, uPAR, and PAI-1 (p<0.05). Tissue concentrations of some components of the plasminogen activator system correlated with clinical and pathological indexes of aggression of tumours, including differentiation and T-stage. CONCLUSION: The relation between components of the plasminogen activator system, in particular uPA, uPAR, and PAI-1 in invasion, metastasis, prognosis, and survival, requires further investigation in oral squamous cell carcinomas.